in English
in English

Yahoo! JAPAN

  • 〜2022
  • 2023〜

MedCheck No 28 (December 2023) New

MedCheck No 28 (December 2023) Download PDF Free

Contents

Editorial
  Unavoidable adverse reactions to Alzheimer s agent

Review
  Lecanemab removes substitute of lost cells leading to brain
  hemorrhage and atrophy

Vaccine Information
     Is it trueSeveral vaccines reduce Alzheimer s disease ?
       Beware of distortion by healthy-vaccine effect

New Products
    GLP-1 agonist for obesity: Semaglutide (Wegovy)
       Too many adverse effects including suicide. Do not use


Errata for line 13-14, left column on p54 (PDF is already corrected)

Before:
           Adrenergic-mediated action is essential for weight
       loss with GLP-1 agonists [16]. 
Corrected: 
            Adrenergic-mediated action is essential for weight
        loss with GLP-1 agonists, because GLP-1 did not decrease
       body weight of triple beta-adrenoreceptor knockout
        mice [16]